We are live on
!
Find out more
IC
IEQ Capital Portfolio holdings
AUM
$21.5B
1-Year Est. Return
75.26%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
+$644M
(+15%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
981
New
89
Increased
388
Reduced
336
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$47.1M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$47M |
| 3 |
Roblox
RBLX
|
+$27.7M |
| 4 |
Joby Aviation
JOBY
|
+$15.4M |
| 5 |
Apple
AAPL
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$12.8M |
| 2 |
CrowdStrike
CRWD
|
+$9.9M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$7.59M |
| 4 |
Silicon Laboratories
SLAB
|
+$7.54M |
| 5 |
Penumbra
PEN
|
+$7.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Communication Services | 13.07% |
| 3 | Consumer Discretionary | 6.86% |
| 4 | Healthcare | 6.72% |
| 5 | Financials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Hewlett Packard
HPE
$69.4B
| $616K | 0.01% |
36,648
-13,057
| -26% | -$200K |
|
502
Boston Properties
BXP
$11.3B
| $615K | 0.01% |
10,682
+4,166
| +64% | +$217K |
|
503
BJs Wholesale Club
BJ
$12.3B
| $613K | 0.01% |
9,724
+464
| +5% | +$32.1K |
|
504
Toast
TOST
$19.6B
| $612K | 0.01% |
27,109
-3,762
| -12% | -$75.1K |
|
505
ResMed
RMD
$32.4B
| $610K | 0.01% |
2,792
-121
| -4% | -$27K |
|
506
Tractor Supply
TSCO
$17.4B
| $608K | 0.01% |
13,750
+25
| +0.2% | +$1.15K |
|
|
CTLP
507
DELISTED
Cantaloupe
CTLP
| $600K | 0.01% |
75,406
| – | – |
|
508
T. Rowe Price
TROW
$24.7B
| $596K | 0.01% |
5,319
-859
| -14% | -$94.1K |
|
509
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
| $591K | 0.01% |
4,272
+46
| +1% | +$6.13K |
|
510
CMS Energy
CMS
$22.5B
| $591K | 0.01% |
10,061
+373
| +4% | +$22.5K |
|
511
iShares US Healthcare Providers ETF
IHF
$1.26B
| $591K | 0.01% |
11,550
| – | – |
|
512
iShares S&P Small-Cap 600 Value ETF
IJS
$8.41B
| $590K | 0.01% |
6,206
| – | – |
|
513
Xylem
XYL
$28.5B
| $587K | 0.01% |
5,209
-839
| -14% | -$88.7K |
|
514
TSMC
TSM
$2.16T
| $586K | 0.01% |
5,805
-1,167
| -17% | -$109K |
|
515
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $584K | 0.01% |
5,320
+81
| +2% | +$8.53K |
|
516
iShares Core S&P US Growth ETF
IUSG
$33.5B
| $584K | 0.01% |
5,982
+14
| +0.2% | +$1.28K |
|
|
NATI
517
DELISTED
National Instruments Corp
NATI
| $579K | 0.01% |
10,087
+34
| +0.3% | +$1.95K |
|
518
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $577K | 0.01% |
6,794
+1,804
| +36% | +$138K |
|
519
Eversource Energy
ES
$27.3B
| $577K | 0.01% |
8,130
+3,068
| +61% | +$228K |
|
520
Essex Property Trust
ESS
$18.5B
| $576K | 0.01% |
2,459
-536
| -18% | -$117K |
|
521
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
| $575K | 0.01% |
12,323
| – | – |
|
522
Hormel Foods
HRL
$13.9B
| $569K | 0.01% |
14,155
+3,885
| +38% | +$156K |
|
523
Willis Towers Watson
WTW
$31.5B
| $565K | 0.01% |
2,401
-623
| -21% | -$144K |
|
524
M&T Bank
MTB
$36.7B
| $562K | 0.01% |
4,540
-1,316
| -22% | -$159K |
|
525
West Pharmaceutical
WST
$24.5B
| $552K | 0.01% |
1,444
+213
| +17% | +$76.1K |
|
Similar funds
DSA
MMH
AM
VARA
SC
BA
IEQ Capital's Q2 2023 Portfolio in Review
As of Q2 2023, IEQ Capital held 981 positions worth $4.96B, up 15% from $4.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
IEQ Capital deployed $171M of net new capital in Q2 2023, opening 89 new positions and adding to 388 existing holdings. Its largest new stake was Neurocrine Biosciences: 481,268 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Salesforce, an estimated $12.8M trimmed.
- IEQ Capital's largest Q2 2023 buy was Neurocrine Biosciences: 481,268 shares worth $45.4M.
- IEQ Capital added most to Upbound Group in Q2 2023, an estimated $47.1M increase.
- IEQ Capital's biggest Q2 2023 reduction was Salesforce, cutting an estimated $12.8M.
- IEQ Capital fully exited Penumbra in Q2 2023, selling an estimated $7.08M.
- IEQ Capital's ten largest holdings make up 38% of its $4.96B portfolio in Q2 2023.
- IEQ Capital opened 89 new positions and closed 81 in Q2 2023.
- IEQ Capital's portfolio value rose 15% quarter-over-quarter to $4.96B.
Based on IEQ Capital's 13F filing for Q2 2023, filed 8 Aug 2023.